Tech Company Financing Transactions
Carvolix Funding Round
Carvolix secured a $34.5 million investment round on 8/6/2026. Backers included Claret Capital Partners.
Transaction Overview
Company Name
Announced On
8/6/2026
Transaction Type
Debt
Amount
$34,500,000
Round
Undisclosed
Investors
Claret Capital Partners (Joey Mason)
Proceeds Purpose
This debt financing gives us specific means directed towards the commercialization of TAVIPILOT and preparation of industrialization across our portfolio.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
320 avenue Archimède, Les pléiades III Batiment B
Aix-en-Provence, 13100
France
Aix-en-Provence, 13100
France
Phone
Website
Email Address
Overview
Carvolix is a French MedTech company at commercial and clinical stage, founded by Truffle Capital, with the ambition to become a global leader in the treatment of structural heart disease and ischemic stroke, two of the world's leading causes of mortality and disability. Carvolix develops novel AI- and imaging-driven mini-robots that enable interventional cardiologists to perform complex procedures more effectively, alongside next-generation biomimetic heart valves.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 8/5/2026: conmeet venture capital transaction
Next: 8/6/2026: Vedanta Biosciences venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








